High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis

Gut

Volumn 49, Issue 5, 2001, Pages 671-677

  Fleshner, P R ^a   Vasiliauskas, E A ^a   Kam, L Y ^a   Fleshner, N E ^b   Gaiennie, J ^a   Abreu Martin, M T ^a   Targan, S R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Ileal pouch anal anastomosis; Inflammatory bowel disease; Perinuclear antineutrophil cytoplasmic antibody; Pouchitis; Ulcerative colitis

Indexed keywords

CYCLOSPORIN; MERCAPTOPURINE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHRONIC DISEASE; COLON RESECTION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENDOSCOPIC SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; SCHOOL CHILD; SERODIAGNOSIS; ULCERATIVE COLITIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; CHILD; CHRONIC DISEASE; COLITIS, ULCERATIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MIDDLE AGED; POUCHITIS; PREDICTIVE VALUE OF TESTS; PROCTOCOLECTOMY, RESTORATIVE; PROSPECTIVE STUDIES; STATISTICS;

EID: 0034775034     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.49.5.671     Document Type: Article

References (41)

1. Long-term results of the ileoanal pouch procedure
2. Ileal pouch-anal anastomoses complications and function in 1005 patients
3. J ileal pouch-anal anastomosis for chronic ulcerative colitis: Complications and long-term outcome in 1310 patients
4. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis
5. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis
6. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease
7. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. a correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment
8. Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis
9. Anti-saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role
10. pANCA represents a cross-reactivity to enteric bacterial antigens
11. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope
12. Clinical and functional outcome after restorative proctocolectomy
13. Postoperative and long-term results of ileal pouch-anal anastomosis for ulcerative colitis and familial polyposis coli
14. Rectal squamous mucosectomy and ileal anal pull-through procedures: Single surgeon experience in 105 patients
15. Prospective study of the incidence, timing, and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy
16. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis
17. Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis
18. Perinuclear antineutrophil cytoplasmic antibody in pouchitis after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis
19. Perinuclear antineutrophil cytoplasmic antibodies in ulcerative colitis after restorative proctocolectomy do not correlate with the presence of pouchitis
20. p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis
21. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis
22. Antineutrophil cytoplasmic antibody subtypes in children and adolescents after ileal pouch-anal anastomosis for ulcerative colitis
23. Segregation of pANCA antigenic recognition by DNAse treatment of neutrophils: Ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis
24. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics
25. Anti-neutrophil cytoplasmic antibodies in ulcerative coltis: Comparison with other colitides/diarrheal illnesses
26. Antineutrophil cytoplasmic antibody in inflammatory bowel diseases
27. Neutrophil autoantibodies: A genetic marker in primary cholangitis and ulcerative colitis
28. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: Results of a pilot study
29. Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: Sensitivity, specificity and recognition of putative antigens
30. Long-term observation of the perinuclear anti-cytoplasmic antibody status in ulcerative colitis patients
31. Clinical heterogeneity of ulcerative colitis in relation to frequency of pANCA reactivity
32. Ileostomy
33. The ileal reservoir and ileoanal anastomosis procedure: Factors affecting technical and functional outcome
34. The clinical and functional outcome after restorative proctocolectomy: A prospective study in 100 patients
35. The first year with a J-pouch
36. Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch
37. Pouchitis following pelvic pouch operation for ulcerative colitis: Incidence, cumulative risk, and risk factors
38. Functional results after restorative proctocolectomy complicated by pouchitis
39. Cytokine production in pouchitis is similar to that in ulcerative colitis
40. Pouchitis after ileal pouch-anal anastomosis: A pouchitis disease activity index
41. Utility of perinuclear anti-neutrophil cytoplasmic antibodies (pANCA), anti-Saccharomyces cerevisiae (ASCA), and anti-pancreatic antibodies (APA) as serologic markers in a population cohort of patients with Crohn's disease (CD) and ulcerative colitis (UC)